Extracorporeal photopheresis for graft‐versus‐host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from a large single‐center study

Citations Over TimeTop 13% of 2014 papers

Abstract

While confirming a higher probability of GVHD responses for early GVHD, our study shows no role of hematologic values or apheresis cell count on GVHD response.

Related Papers

• Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.(1994)
• → The role of extracorporeal photopheresis in chronic graft-versus-host disease(2015)10 cited
• Extracorporeal Photopheresis for Non-skin GvHD.(2016)
• → Safety and Outcomes of Extracorporeal Photopheresis with the Therakos Cellex System for Graft Versus Host Disease in Pediatric Patients(2014)1 cited
• → Clinical evidence for extracorporeal photopheresis in the treatment of chronic graft-versus-host disease(2021)